MKS Instruments, Inc. (MKSI) Receives Average Rating of “Buy” from Analysts

MKS Instruments, Inc. (NASDAQ:MKSI) has earned a consensus rating of “Buy” from the seven brokerages that are covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company. The average 1-year price target among brokerages that have covered the stock in the last year is $133.33.

Several equities research analysts recently weighed in on MKSI shares. BidaskClub downgraded shares of MKS Instruments from a “buy” rating to a “hold” rating in a research note on Thursday, January 11th. Stifel Nicolaus reaffirmed a “buy” rating and set a $133.00 target price on shares of MKS Instruments in a research note on Thursday, February 1st. ValuEngine raised shares of MKS Instruments from a “hold” rating to a “buy” rating in a research report on Friday, February 2nd. KeyCorp reissued a “buy” rating on shares of MKS Instruments in a research report on Friday, February 2nd. Finally, Dougherty & Co reissued a “buy” rating on shares of MKS Instruments in a research report on Sunday, February 4th.

In other MKS Instruments news, Director Peter Hanley sold 430 shares of the stock in a transaction that occurred on Wednesday, March 14th. The shares were sold at an average price of $123.40, for a total value of $53,062.00. Following the sale, the director now directly owns 1,992 shares of the company’s stock, valued at approximately $245,812.80. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Elizabeth Mora sold 300 shares of the stock in a transaction that occurred on Thursday, March 1st. The shares were sold at an average price of $111.10, for a total transaction of $33,330.00. Following the completion of the sale, the director now directly owns 15,554 shares in the company, valued at $1,728,049.40. The disclosure for this sale can be found here. Over the last three months, insiders sold 31,443 shares of company stock worth $3,603,392. Insiders own 1.67% of the company’s stock.

Several institutional investors have recently modified their holdings of the company. Wells Fargo & Company MN boosted its holdings in shares of MKS Instruments by 132.5% in the 4th quarter. Wells Fargo & Company MN now owns 902,995 shares of the scientific and technical instruments company’s stock valued at $85,333,000 after buying an additional 514,563 shares in the last quarter. Renaissance Technologies LLC boosted its holdings in shares of MKS Instruments by 15.5% in the 4th quarter. Renaissance Technologies LLC now owns 685,300 shares of the scientific and technical instruments company’s stock valued at $64,761,000 after buying an additional 92,048 shares in the last quarter. Victory Capital Management Inc. boosted its holdings in shares of MKS Instruments by 7.9% in the 4th quarter. Victory Capital Management Inc. now owns 488,173 shares of the scientific and technical instruments company’s stock valued at $46,131,000 after buying an additional 35,684 shares in the last quarter. Schwab Charles Investment Management Inc. boosted its holdings in shares of MKS Instruments by 1.8% in the 4th quarter. Schwab Charles Investment Management Inc. now owns 474,986 shares of the scientific and technical instruments company’s stock valued at $44,887,000 after buying an additional 8,597 shares in the last quarter. Finally, Westwood Holdings Group Inc. boosted its holdings in shares of MKS Instruments by 27.7% in the 4th quarter. Westwood Holdings Group Inc. now owns 390,755 shares of the scientific and technical instruments company’s stock valued at $36,926,000 after buying an additional 84,718 shares in the last quarter. Institutional investors and hedge funds own 94.00% of the company’s stock.

Shares of MKSI opened at $103.55 on Thursday. MKS Instruments has a fifty-two week low of $65.90 and a fifty-two week high of $128.28. The company has a market cap of $5,775.81, a P/E ratio of 17.37, a price-to-earnings-growth ratio of 1.01 and a beta of 0.92. The company has a current ratio of 4.27, a quick ratio of 3.10 and a debt-to-equity ratio of 0.25.

MKS Instruments (NASDAQ:MKSI) last announced its earnings results on Tuesday, April 24th. The scientific and technical instruments company reported $2.07 earnings per share for the quarter, topping the consensus estimate of $2.00 by $0.07. MKS Instruments had a net margin of 17.70% and a return on equity of 22.51%. The firm had revenue of $554.00 million for the quarter, compared to the consensus estimate of $530.68 million. During the same period in the prior year, the firm earned $1.27 EPS. The firm’s revenue for the quarter was up 26.7% on a year-over-year basis. research analysts forecast that MKS Instruments will post 7.89 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION WARNING: “MKS Instruments, Inc. (MKSI) Receives Average Rating of “Buy” from Analysts” was originally published by Ticker Report and is owned by of Ticker Report. If you are accessing this story on another domain, it was stolen and republished in violation of United States & international copyright & trademark laws. The correct version of this story can be accessed at https://www.tickerreport.com/banking-finance/3390016/mks-instruments-inc-mksi-receives-average-rating-of-buy-from-analysts.html.

MKS Instruments Company Profile

MKS Instruments, Inc provides instruments, subsystems, and process control solutions that measure, control, power, deliver, monitor, and analyze critical parameters of manufacturing processes worldwide. The company operates through two segments, Vacuum & Analysis and Light & Motion. The Vacuum & Analysis segment provides analytical and control solutions products, including gas analyzers, automation control products, I/O modules, automation software, and precision machined components and electromechanical assemblies; and materials delivery solutions products comprising flow and valve technologies, as well as integrated pressure measurement and control subsystems to provide customers with precise control capabilities that are optimized for a given application.

Receive News & Ratings for MKS Instruments Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MKS Instruments and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

IOStoken   Trading 19.2% Lower  This Week
IOStoken Trading 19.2% Lower This Week
Primas  Price Tops $0.70
Primas Price Tops $0.70
Oxford Immunotec Global  Rating Increased to Buy at BidaskClub
Oxford Immunotec Global Rating Increased to Buy at BidaskClub
Nabriva Therapeutics  Price Target Raised to $11.00
Nabriva Therapeutics Price Target Raised to $11.00
Intec Pharma  PT Set at $16.00 by HC Wainwright
Intec Pharma PT Set at $16.00 by HC Wainwright
Federated National Holding Co Common Stock  Hits New 1-Year High and Low at $22.51
Federated National Holding Co Common Stock Hits New 1-Year High and Low at $22.51


© 2006-2018 Ticker Report. Google+.